← FDA Drug Approvals (Drugs@FDA)

BYDUREON BCISE

NDA · New Drug Application · Sponsor: ASTRAZENECA AB · Approved 2017-10-20

Drug application

FDA Application #

NDA209210

Application type

New Drug Application

Brand name

BYDUREON BCISE

Generic name

Exenatide Synthetic

Active ingredients

EXENATIDE SYNTHETIC

Dosage form

SUSPENSION, EXTENDED RELEASE

Route

SUBCUTANEOUS

Marketing status

Discontinued

Sponsor

ASTRAZENECA AB

First approval

2017-10-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown